Compound ID | 1504
Class: Nitroimidazole
| Spectrum of activity: | Gram-positive |
| Details of activity: | Effective against C. difficile and Fusobacterium infections. Only effective against anaerobic bacteria. |
| Institute where first reported: | Pfizer, USA |
| Year first mentioned: | 1960 |
| Highest development stage: | Approved by FDA in 1995 |
| Development status: | Approved |
| Reason dropped: | Other formulations were discontinued |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/4173 |
| Guide to Pharmacology: | metronidazole |
| Citations: |
|